Your browser doesn't support javascript.
loading
Pregabalin-Induced Bullous Pemphigoid: A Case Report of a Rare Drug-Triggered Autoimmune Skin Disorder.
Tovar, Rachel; Jones, Daniel T; Srinivasmurthy, Ramaditya; Pandit, Meghana; Ho, Liawaty.
Afiliação
  • Tovar R; Internal Medicine, Touro University Nevada College of Osteopathic Medicine, Henderson, USA.
  • Jones DT; Internal Medicine, Touro University Nevada College of Osteopathic Medicine, Henderson, USA.
  • Srinivasmurthy R; Internal Medicine, Touro University Nevada College of Osteopathic Medicine, Henderson, USA.
  • Pandit M; Internal Medicine, Touro University Nevada College of Osteopathic Medicine, Henderson, USA.
  • Ho L; Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, USA.
Cureus ; 16(9): e69649, 2024 Sep.
Article em En | MEDLINE | ID: mdl-39296925
ABSTRACT
Bullous pemphigoid (BP) is a common autoimmune blistering disorder primarily affecting the elderly, characterized by intense pruritus and tense bullae on the skin. We report the case of a 75-year-old female with a history of breast cancer who developed BP on both feet following the initiation of pregabalin for pain management. Histopathological examination confirmed BP, and symptoms improved with topical corticosteroid treatment and discontinuation of pregabalin. This case highlights the potential of pregabalin to induce BP and underscores the importance of recognizing medication-induced bullous diseases for prompt diagnosis and management.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos